Medical treatment of benign prostatic hyperplasia
- PMID: 17308208
- PMCID: PMC2805943
- DOI: 10.1136/pgmj.2006.050724
Medical treatment of benign prostatic hyperplasia
Abstract
Pharmaceutical preparations are commonly used for benign prostate hyperplasia. This article reviews the current understanding of the natural history of the condition and the literature regarding medical treatment.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Dutasteride and prostate cancer.N Engl J Med. 2010 Aug 19;363(8):794; author reply 794-6. doi: 10.1056/NEJMc1005498. N Engl J Med. 2010. PMID: 20842790 No abstract available.
-
Re: The Effects of Combination Therapy With Dutasteride and Tamsulosin on Clinical Outcomes in Men With Symptomatic Benign Prostatic Hyperplasia: 4-Year Results From the CombAT Study.J Urol. 2011 Apr;185(4):1384-5. doi: 10.1016/j.juro.2010.12.080. Epub 2011 Feb 19. J Urol. 2011. PMID: 22115487 No abstract available.
-
[Dual 5-alpha reductase inhibitors in BPH (benign prostatic hyperplasia). Already after 1 month prostate shrinks].MMW Fortschr Med. 2003 Feb 27;145(9):54. MMW Fortschr Med. 2003. PMID: 12666533 German. No abstract available.
-
Current status of 5alpha-reductase inhibitors in the treatment of benign hyperplasia of prostate.Indian J Med Sci. 2008 Apr;62(4):167-75. Indian J Med Sci. 2008. PMID: 18445985 Review.
-
[Pharmacologic treatment of benign prostatic hyperplasia].Orv Hetil. 2003 Sep 14;144(37):1809-14. Orv Hetil. 2003. PMID: 14596018 Review. Hungarian.
Cited by
-
Discovery of Lignans from the Herbs of Peperomia heyneana with Inhibitory Activities on BPH-1 Cells.Molecules. 2025 Apr 17;30(8):1809. doi: 10.3390/molecules30081809. Molecules. 2025. PMID: 40333839 Free PMC article.
References
-
- Girman C J, Jacobsen S J, Tsukamoto T.et al Heath‐related quality of life associated with lower urinary tract symptoms in four countries. Urology 199851428–436. - PubMed
-
- Sells H, Donovan J, Ewings P.et al The development and validation of a quality of life measure to assess partner morbidity in benign prostatic enlargement. BJU Int 200085440–445. - PubMed
-
- Bruskewitz R. Management of symptomatic BPH in the US: who is treated and how? Eur Urol 199936(Suppl 3)7–13. - PubMed
-
- Holtgrewe H, Mebust W, Dowd J.et al Transurethral prostatectomy: practice aspects of the dominant operation in American urology. J Urol 1989141248–253. - PubMed
-
- Xia Z, Roberts R O, Schottenfeld D.et al Trends in prostatectomy for benign prostatic hyperplasia among black and white men in the United States: 1980–94. Urology 1999531154–1159. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical